Opportunistic pathogen Candida albicans elicits a temporal response in primary human mast cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lopes, José Pedro ^a,b   Stylianou, Marios ^a,b   Nilsson, Gunnar ^c   Urban, Constantin F ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b Molecular Infection Medicine Sweden (MIMS)   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CHEMOTACTIC FACTOR; CYTOKINE;

CANDIDA ALBICANS; CANDIDIASIS; CELL CULTURE; CELL DEATH; DEGRANULATION; DRUG EFFECTS; ENDOCYTOSIS; EXTRACELLULAR TRAP; HUMAN; MAST CELL; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MONOCYTE; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TIME FACTOR;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; CELL DEATH; CELL DEGRANULATION; CELLS, CULTURED; CHEMOTACTIC FACTORS; CYTOKINES; ENDOCYTOSIS; EXTRACELLULAR TRAPS; HUMANS; MAST CELLS; MICROBIAL VIABILITY; MONOCYTES; NEUTROPHILS; TIME FACTORS;

EID: 84937801481     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12287     Document Type: Article

References (62)

1. Mikulska, M., Del Bono, V., Ratto, S. & Viscoli, C. Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol 8, 755-765, doi: 10.1586/eci.12.52 (2012).
2. Patterson, T. F. Advances and challenges in management of invasive mycoses. Lancet 366, 1013-1025, doi: 10.1016/S0140-6736(05)67381-3 (2005).
3. Montravers, P. et al. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 17, 1061-1067, doi: 10.1111/j.1469-0691.2010.03360.x (2011).
4. Bassetti, M. et al. Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain. J Clin Microbiol 51, 4167-4172, doi: 10.1128/JCM.01998-13 (2013).
5. Abraham, S. N. & St John, A. L. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol 10, 440-452, doi: 10.1038/ nri2782 (2010).
6. von Kockritz-Blickwede, M. et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111, 3070-3080, doi: 10.1182/blood-2007-07-104018 (2008).
7. Cruse, G. et al. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin. J Immunol 184, 7108-7115, doi: 10.4049/jimmunol.0900802 (2010).
8. Rodriguez, A. R. et al. Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis. J Immunol 188, 5604-5611, doi: 10.4049/jimmunol.1200039 (2012).
9. Selander, C., Engblom, C., Nilsson, G., Scheynius, A. & Andersson, C. L. TLR2/MyD88-dependent and -independent activation of mast cell IgE responses by the skin commensal yeast Malassezia sympodialis. J Immunol 182, 4208-4216, doi: 10.4049/ jimmunol.0800885 (2009).
10. Urb, M., Pouliot, P., Gravelat, F. N., Olivier, M. & Sheppard, D. C. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J Infect Dis 200, 464-472, doi: 10.1086/600070 (2009).
11. Saluja, R., Metz, M. & Maurer, M. Role and relevance of mast cells in fungal infections. Front Immunol 3, 146, doi: 10.3389/ fimmu.2012.00146 (2012).
12. Urb, M. & Sheppard, D. C. The role of mast cells in the defence against pathogens. PLoS Pathog 8, e1002619, doi: 10.1371/journal.ppat.1002619 (2012).
13. Supajatura, V. et al. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109, 1351-1359, doi: 10.1172/JCI14704 (2002).
14. Scheb-Wetzel, M., Rohde, M., Bravo, A. & Goldmann, O. New Insights into the Antimicrobial Effect of Mast Cells against Enterococcus faecalis. Infect Immun 82, 4496-4507, doi: 10.1128/IAI.02114-14 (2014).
15. Carlos, D. et al. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect 11, 770-778, doi: 10.1016/j.micinf.2009.04.025 (2009).
16. Inoue, M. & Shinohara, M. L. Clustering of pattern recognition receptors for fungal detection. PLoS Pathog 10, e1003873, doi: 10.1371/journal.ppat.1003873 (2014).
17. Shoham, S., Huang, C., Chen, J. M., Golenbock, D. T. & Levitz, S. M. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol 166, 4620-4626 (2001).
18. Kimura, Y. et al. Dectin-1-mediated signaling leads to characteristic gene expressions and cytokine secretion via spleen tyrosine kinase (Syk) in rat mast cells. J Biol Chem 289, 31565-31575, doi: 10.1074/jbc.M114.581322 (2014).
19. Olynych, T. J., Jakeman, D. L. & Marshall, J. S. Fungal zymosan induces leukotriene production by human mast cells through a dectin-1-dependent mechanism. J Allergy Clin Immunol 118, 837-843, doi: 10.1016/j.jaci.2006.06.008 (2006).
20. Yang, Z. & Marshall, J. S. Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology 214, 321-330, doi: 10.1016/j.imbio.2008.09.002 (2009).
21. Wernersson, S. & Pejler, G. Mast cell secretory granules: armed for battle. Nat Rev Immunol 14, 478-494, doi: 10.1038/nri3690 (2014).
22. Maurer, M. et al. Skin mast cells control T cell-dependent host defense in Leishmania major infections. FASEB J 20, 2460-2467, doi: 10.1096/fj.06-5860com (2006).
23. Echtenacher, B., Mannel, D. N. & Hultner, L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381, 75-77, doi: 10.1038/381075a0 (1996).
24. Fukuishi, N. et al. Does beta-Hexosaminidase Function Only as a Degranulation Indicator in Mast Cells? The Primary Role of beta-Hexosaminidase in Mast Cell Granules. J Immunol 193, 1886-1894, doi: 10.4049/jimmunol.1302520 (2014).
25. Caughey, G. H. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217, 141-154, doi: 10.1111/j.1600-065X.2007.00509.x (2007).
26. Oh, S. W. et al. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J Immunol 168, 1992-2000 (2002).
27. Marshall, J. S. Mast-cell responses to pathogens. Nat Rev Immunol 4, 787-799, doi: 10.1038/nri1460 (2004).
28. Shin, K. et al. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J Immunol 180, 4885-4891 (2008).
29. Thakurdas, S. M. et al. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem 282, 20809-20815, doi: 10.1074/jbc.M611842200 (2007).
30. Wang, B. et al. Cutting edge: Deficiency of macrophage migration inhibitory factor impairs murine airway allergic responses. J Immunol 177, 5779-5784 (2006).
31. Rumsaeng, V. et al. Human mast cells produce the CD4+ T lymphocyte chemoattractant factor, IL-16. J Immunol 159, 2904-2910 (1997).
32. Hosseinzadeh, A., Messer, P. K. & Urban, C. F. Stable Redox-Cycling Nitroxide Tempol Inhibits NET Formation. Front Immunol 3, 391, doi: 10.3389/fimmu.2012.00391 (2012).
33. Lin, A. M. et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 187, 490-500, doi: 10.4049/jimmunol.1100123 (2011).
34. Scheb-Wetzel, M., Rohde, M., Bravo, A. & Goldmann, O. New insights into the antimicrobial effect of mast cells against Enterococcus faecalis. Infect Immun. doi: 10.1128/IAI.02114-14 (2014).
35. Guery, B. P. et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 35, 55-62, doi: 10.1007/s00134-008-1338-7 (2009).
36. Trevisan, E. et al. Mast Cells Kill Candida albicans in the Extracellular Environment but Spare Ingested Fungi from Death. Inflammation. doi: 10.1007/s10753-014-9951-9 (2014).
37. Sakurai, A., Yamaguchi, N. & Sonoyama, K. Cell Wall Polysaccharides of Candida albicans Induce Mast Cell Degranulation in the Gut. Biosci Microbiota Food Health 31, 67-70, doi: 10.12938/bmfh.31.67 (2012).
38. Dongari-Bagtzoglou, A. & Kashleva, H. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 34, 169-177 (2003).
39. Schramm, R., Schaefer, T., Menger, M. D. & Thorlacius, H. Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone. J Leukoc Biol 72, 1122-1132 (2002).
40. De Filippo, K. et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121, 4930-4937, doi: 10.1182/blood-2013-02-486217 (2013).
41. Pimentel, T. A., Sampaio, A. L., D'Acquisto, F., Perretti, M. & Oliani, S. M. An essential role for mast cells as modulators of neutrophils influx in collagen-induced arthritis in the mouse. Lab Invest 91, 33-42, doi: 10.1038/labinvest.2010.140 (2011).
42. Weber, F. C. et al. Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity. J Exp Med 212, 15-22, doi: 10.1084/jem.20130062 (2015).
43. Butler, J. T., Samantaray, S., Beeson, C. C., Ray, S. K. & Banik, N. L. Involvement of calpain in the process of Jurkat T cell chemotaxis. J Neurosci Res 87, 626-635, doi: 10.1002/jnr.21882 (2009).
44. Noverr, M. C., Noggle, R. M., Toews, G. B. & Huffnagle, G. B. Role of antibiotics and fungal microbiota in driving pulmonary allergic responses. Infect Immun 72, 4996-5003, doi: 10.1128/IAI.72.9.4996-5003.2004 (2004).
45. Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532-1535, doi: 10.1126/science.1092385 (2004).
46. Simon, D. et al. Eosinophil extracellular DNA traps in skin diseases. J Allergy Clin Immunol 127, 194-199, doi: 10.1016/j.jaci.2010.11.002 (2011).
47. Mohanan, S., Horibata, S., McElwee, J. L., Dannenberg, A. J. & Coonrod, S. A. Identification of macrophage extracellular trap-like structures in mammary gland adipose tissue: a preliminary study. Front Immunol 4, 67, doi: 10.3389/fimmu.2013.00067 (2013).
48. Morshed, M. et al. NADPH Oxidase-Independent Formation of Extracellular DNA Traps by Basophils. J Immuno. doi: 10.4049/ jimmunol.1303418 (2014).
49. Moretti, S. et al. The contribution of PARs to inflammation and immunity to fungi. Mucosal Immunol 1, 156-168, doi: 10.1038/ mi.2007.13 (2008).
50. Zhu, W. & Filler, S. G. Interactions of Candida albicans with epithelial cells. Cell Microbiol 12, 273-282, doi: 10.1111/j.1462-5822.2009.01412.x (2010).
51. O'Meara, T. R. et al. Global analysis of fungal morphology exposes mechanisms of host cell escape. Nat Commun 6, 6741, doi: 10.1038/ncomms7741 (2015).
52. Uwamahoro, N. et al. The pathogen Candida albicans hijacks pyroptosis for escape from macrophages. MBio 5, e00003-00014, doi: 10.1128/mBio.00003-14 (2014).
53. McAlpine, S. M., Enoksson, M., Lunderius-Andersson, C. & Nilsson, G. The effect of bacterial, viral and fungal infection on mast cell reactivity in the allergic setting. J Innate Immun 3, 120-130, doi: 10.1159/000323350 (2011).
54. Gillum, A. M., Tsay, E. Y. & Kirsch, D. R. Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198, 179-182 (1984).
55. Gerami-Nejad, M., Dulmage, K. & Berman, J. Additional cassettes for epitope and fluorescent fusion proteins in Candida albicans. Yeast 26, 399-406, doi: 10.1002/yea.1674 (2009).
56. Care, R. S., Trevethick, J., Binley, K. M. & Sudbery, P. E. The MET3 promoter: a new tool for Candida albicans molecular genetics. Mol Microbiol 34, 792-798 (1999).
57. Fonzi, W. A. & Irwin, M. Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134, 717-728 (1993).
58. Staab, J. F., Bahn, Y. S. & Sundstrom, P. Integrative, multifunctional plasmids for hypha-specific or constitutive expression of green fluorescent protein in Candida albicans. Microbiology 149, 2977-2986 (2003).
59. Butterfield, J. H., Weiler, D., Dewald, G. & Gleich, G. J. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12, 345-355 (1988).
60. Xiang, Z., Moller, C. & Nilsson, G. IgE-receptor activation induces survival and Bfl-1 expression in human mast cells but not basophils. Allergy 61, 1040-1046, doi: 10.1111/j.1398-9995.2006.01024.x (2006).
61. Ekoff, M., Moller, C., Xiang, Z. & Nilsson, G. Coaggregation of FcepsilonRI with FcgammaRIIB Inhibits Degranulation but Not Induction of Bcl-2 Family Members A1 and Bim in Mast Cells. Allergy Asthma Clin Immunol 2, 87-97, doi: 10.1186/1710-1492-2-3-87 (2006).
62. Stylianou, M. et al. Antifungal application of nonantifungal drugs. Antimicrob Agents Chemother 58, 1055-1062, doi: 10.1128/ AAC.01087-13 (2014).